Anti-viral activity of the methanolic leaf extract of an Iranian medicinal plant "Hyssopus officinalis" against herpes simplex virus

Journal of Medicinal Plants Research

Volumn 3, Issue 12, 2009, Pages 1118-1125

  Behbahani, Mandana ^a  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

Author keywords

Anti viral activity; Herpes simplex virus; Hyssopus officinalis

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; HYSSOPUS OFFICINALIS EXTRACT; METHANOL; PLANT EXTRACT; UNCLASSIFIED DRUG;

ACUTE TOXICITY; ANGIOSPERM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ANTIVIRAL RESISTANCE; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFICACY; FEMALE; HERPES SIMPLEX; HERPES SIMPLEX VIRUS; HYSSOPUS OFFICINALIS; MALE; MORTALITY; MOUSE; NONHUMAN; PLANT LEAF; PLAQUE FORMING CELL; SURVIVAL TIME; VERO CELL; VIRUS PLAQUE; VIRUS STRAIN; WILD TYPE;

HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 2; HYSSOPUS OFFICINALIS; MURINAE; MUS; SIMPLEXVIRUS;

EID: 75649106082     PISSN: 19960875     EISSN: 19960875     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Fatahzadeh M, Schwartz R (2007). Human herpes simplex virus infections: Epidemiology, pathogenesis, symptomatology, diagnosis, and management. J. Am. Acad. Dermatol. 57(5): 737-763.
2. Kazazi H, Rezaei K, Ghotb-Sharif J, Emam-jomeh Z, Yamini Y (2007).Supercriticial fluid extraction of flavors and fragrances from Hyssopus officinalis L. cultivated in Iran, Food Chem. 210(5): 805-811
3. Kleymann G (2003). Novel agents and strategies to treat herpes simplex infections. Expert Opin. Investig. Drugs. 12: 165-183.
4. Kurokawa M, Sato H, Ohyama H, Hozumi T, Namba T, Kawana T, Shiraki K (1995). Effects of traditional herbal medicines against herpes simplex virus (HSV) type 2 and acyclovir resistant HSV type 1 in vitro and in vivo. J. Trad. Med. 12: 187-194.
5. Kurokawa M, Hozumi T, Basnet P, Nakano M, Kadota TN, Kawana T, Shiraki K (1998). Purification and characterization of Eugeniin as an anti-herpesvirus compound from Geum japonicum and Syzygium aromaticum. J. Pharmacol. Exp. Ther. 284: 728-735.
6. Kurokawa M, Hozumi T, Tsurita M, Kadota S, Namba T, Shiraki K (2001). Biological characterization of Eugeniin as an anti-herpes simplex virus type 1 compound in vitro and in vivo. J. Pharmacol. Exp. Ther. 297: 372-379.
7. Kurokawa M, Ochine H, Nagasaka K, Neki M, Xu H, Kadota S, Sutardjo S, Matsumoto T, Namba T, Shiruki K (1993). Antiviral traditional medicines against herpes simplex virus (HSV-1), poliovirus and measles virus in vitro and their therapeutic efficacies for HSV-1 infection in mice. Antiviral Res. 22: 175-188.
8. Miserocchi E, Modorati G, Galli L, Rama P (2007), Efficacy of Valacyclovir vs Acyclovir for the Prevention of Recurrent Herpes Simplex Virus Eye Disease: A Pilot Study, Am. J. Ophthalmol. 144(4): 547-551.
9. Morfin F, Thouvenot D (2003), Herpes simplex virus resistance to antiviral drugs, J. Clin. Virol. 26(1): 29-37.
10. Mbopi-Keou F-X, Gresenguet G, Mayaud P, Weiss HA, Gopal R, Matta M, Paul J-L., Brown DWG, Hayes RJ, Mabey DCW, Belec L (2000). Interactions between herpes simplex virus type 2 and human immunodeficiency virus type 1 infection in African women. J. Infect. Dis. 182: 1090-1096.
11. Reyes M, Shaik NS, Graber JM, Nisenbaum R, Wetherall NT, Fukuda K, Reeves WC (2003). Acyclovir-resistant genital herpes among persons attending sexually transmitted disease and human immunodeficiency virus clinics. Arch. Intern. Med. 163: 76-80.
12. Safrin S, Ashley R, Houliham C, Cusick PS, Mills J (1991). Clinical and serological features of herpes simplex virus infection in patients with AIDS. AIDS 5: 1107-1110.
13. Shuyun S, Kelong H, Yuping Z, Yu Z, Qizhen D (2007), Purification and identification of antiviral components from Laggera pterodonta by high-speed counter-current chromatography, J. Chromatogr. 859(1): 119-124.
14. Wolfgang KJ, Barry DW, Dekker CL, Forthingham TE, Hamilton JD, Katz SL, Lehrman SN, Wilfert MD (1985). Herpes Simplex Virus. Virology, 2nd ed. Appleton-Century-Crofts, Norwalk, Connecticut, 200-203